Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

10583 from 11319 pages
No results were found for the filter!
TCMDC-136230
TCMDC-136230

Item number: TGM-T62588-100mg

Description: TCMDC-136230 is a novel inhibitor of Plasmodium calcium kinetics with minimal inhibition of haemoglobin crystallisation. Target: Others
MW: 442.62 D
From 1,440.00€ *
Review
AChE-IN-25
AChE-IN-25

Item number: TGM-T62590-100mg

Description: AChE-IN-25 is a selective, potent, non-competitive inhibitor of acetylcholinesterase (AChE) with an IC50 value of 2.95 µM. AChE-IN-25 can be used to study Alzheimer's disease. Target: Others
MW: 442.88 D
From 1,440.00€ *
Review
G092
G092

Item number: TGM-T62595-100mg

Description: G092 is a potent inhibitor of the ABC transporter protein MsbA, holding potential for antibacterial drug research. Target: Others
MW: 443.32 D
From 1,440.00€ *
Review
Sovesudil hydrochloride
Sovesudil hydrochloride

Item number: TGM-T62608-100mg

Description: Sovesudil (PHP-201) hydrochloride is a potent, ATP-competitive Rho kinase (ROCK) inhibitor, acting on ROCK I (IC50: 3.7 nM) and ROCK II (IC50: 2.3 nM), and lowers IOP without causing congestion. Target: Others
MW: 443.9 D
From 1,412.00€ *
Review
CD33 splicing modulator 1
CD33 splicing modulator 1

Item number: TGM-T62612-25mg

Description: CD33 splicing modulator 1 (Compound 1) is a CD33 splicing modulator that targets the CD33/Siglec 3 myeloid cell surface receptor, known for regulating microglial cell activity, and holds potential for studying neurodegenerative diseases such as Alzheimer's disease. Target: Others
MW: 444.5 D
2,175.00€ *
Review
G247
G247

Item number: TGM-T62623-100mg

Description: G247 is a specific inhibitor of MsbA, a wedge of transmembrane structural domains (TMDs) that symmetrically enhances the separation of nucleotide-binding domains (NBDs) and prevents conformational transitions of MsbA. G247 increases the distance between NBDs, thereby inhibiting ATPase activity. Target:...
MW: 445.31 D
From 1,440.00€ *
Review
Antibacterial agent 69
Antibacterial agent 69

Item number: TGM-T62627-100mg

Description: Antibacterial agent 69 is a novel structural antimicrobial modulator that can be used against lethal multidrug-resistant bacterial infections (MIC: 2.978 µM). Target: Others
MW: 445.49 D
From 1,440.00€ *
Review
HPK1-IN-21
HPK1-IN-21

Item number: TGM-T62632-100mg

Description: HPK1-IN-21 is a potent, orally active HPK1 kinase inhibitor with a Ki value of 0.8 nM. Target: Others
MW: 445.92 D
From 1,440.00€ *
Review
K027
K027

Item number: TGM-T62634-100mg

Description: K027 is a potent organophosphate (OP) inhibitor of acetylcholinesterase (AChE) reactivation. k027 can be used to study Alzheimer's disease. Target: Others
MW: 446.14 D
From 1,440.00€ *
Review
MsbA-IN-1
MsbA-IN-1

Item number: TGM-T62636-100mg

Description: MsbA-IN-1 is a potent inhibitor of MsbA (IC50: 4 nM). MsbA-IN-1 has anti-E. coli activity (MIC: 79 µM). MsbA-IN-1 fully penetrates the outer membrane of Gram-negative bacteria and exhibits inhibition of MsbA. Target: Others
MW: 446.3 D
From 1,440.00€ *
Review
FPR2 agonist 2
FPR2 agonist 2

Item number: TGM-T62640-100mg

Description: FPR2 agonist 2 is a potent FPR2 agonist with blood-brain barrier permeability that acts on h-FPR2 (EC50: 0.13 nM), inhibiting the production of pro-inflammatory cytokines, counteracting changes in mitochondrial function, and inhibiting caspase-3 activity. Target: Others
MW: 446.45 D
From 747.00€ *
Review
Ppardelta agonist 5
Ppardelta agonist 5

Item number: TGM-T62646-100mg

Description: Ppardelta agonist 5 is a selective, orally active PPARdelta agonist with an EC50 of 0.335 µM and better selectivity than GW0742. Ppardelta agonist 5 has a beneficial effect on the improvement of bone density and microarchitecture in vivo. Target: Others
MW: 446.49 D
From 1,440.00€ *
Review
10583 from 11319 pages